• Mashup Score: 4
    ESC Hot Line: Long-term Outcomes Following LAAO with a Watchman: Outcomes from the NCDR - American College of Cardiology - 7 month(s) ago

    The rates of stroke after left atrial appendage occlusion with the Watchman device in real-world clinical practice in the US is relatively low and consistent with those from clinical trials despite the high thromboembolic risk of the patients undergoing the procedure. The rates of death are relatively high in this elderly population with high rates of comorbidities, highlighting the need for shared decision-making regarding the procedure. In this interview, James V. Freeman MD, MPH, MS, and Joseph E.

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      In this #ACCEL Lite podcast, Drs. @jfreeMD, @DrJMarine w/ @purviparwani discuss Long-term Outcomes Following Left Atrial Appendage Occlusion w/ a Watchman Device: Outcomes from the #NCDR. Listen to the podcast here: 🎧 https://t.co/l9eszIcsQ3 #ACCQuality23 #LAAORegistry https://t.co/KGrW8ALx6y

  • Mashup Score: 6
    ESC Hot Line: Long-term Outcomes Following LAAO with a Watchman: Outcomes from the NCDR - American College of Cardiology - 7 month(s) ago

    The rates of stroke after left atrial appendage occlusion with the Watchman device in real-world clinical practice in the US is relatively low and consistent with those from clinical trials despite the high thromboembolic risk of the patients undergoing the procedure. The rates of death are relatively high in this elderly population with high rates of comorbidities, highlighting the need for shared decision-making regarding the procedure. In this interview, James V. Freeman MD, MPH, MS, and Joseph E.

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      On a 🆕 episode of #ACCEL Lite podcast, Drs. @jfreeMD, @DrJMarine & @purviparwani discuss Long-term Outcomes Following LAAO with a Watchman Device: Outcomes from the #NCDR. Listen here: https://t.co/BhPdUgRh1C https://t.co/13gds49hdQ

  • Mashup Score: 0
    ESC Hot Line: STEP HFpEF: Once-Weekly Semaglutide in People with HFpEF and Obesity - American College of Cardiology - 7 month(s) ago

    Currently no approved therapies exist to target obesity-related heart failure with preserved ejection fraction, a condition increasing in prevalence and associated with high symptom burden. In this interview, Mikhail Kosiborod MD, and Alison L. Bailey MD, FACC, discuss ESC Hot Line: STEP HFpEF: once-weekly semaglutide in people with HFpEF and obesity. Kosiborod M, Abildstrøm S, Borlaug B, et al. Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      Currently no approved therapies exist to target obesity-related #HFpEF, a condition increasing in prevalence and associated with high symptom burden. Listen to Drs. @MkosiborodMD & @a_l_bailey discuss the STEP HFpEF trial on the #ACCEL Lite podcast. 🎧 https://t.co/IuCbddJw1N https://t.co/I4vCCPbQMn

  • Mashup Score: 1
    ESC Late-Breaker: RATE-AF Trial Wearables Study - American College of Cardiology - 8 month(s) ago

    What is known about the use of wearables and their impact on health outcomes and healthcare use among patients with atrial fibrillation. In this interview, Dipak Kotecha MBChB, PhD and Sidney C. Smith Jr. MD, MACC, discuss “ESC Late-Breaker: RATE-AF trial wearables study.” Bunting KV, Stanbury M, Tica O, Kotecha D. Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial. Eur Heart J. 2021 Jul 1;42(25):2411-2414. doi: 10.1093/eurheartj/ehab098. PMID: 33655299;

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      The RATE-AF trial concluded consumer wearable devices are an exciting opportunity to gain information on dynamic physiological parameters. Listen to Drs. Dipak Kotecha & Sidney C. Smith Jr. discuss the trial on the #ACCEL Lite podcast: https://t.co/HdL8iDglxy https://t.co/xgAEJQDqRu

  • Mashup Score: 2
    ACCEL Lite: Contemporary Therapy in PAD That Every Cardiologist Should Know - American College of Cardiology - 8 month(s) ago

    Understanding, recognizing and effectively treating PAD has the potential to dramatically alter a patient’s life. A patient’s ability to walk, quality of life, and longevity can all be profoundly impacted. In this interview, Sasanka Jayasuriya, MD, FACC, Douglas Weaver MD, MACC, and Sun Moon Kim MD, FSCAI, FACC, discuss Contemporary Therapy in PAD That Every Cardiologist Should Know. Father A, Menard MT, Conte MS, et al., on behalf of the Best-CLI investigators. Surgery or Endovascular Therapy for

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      Understanding, recognizing & treating PAD has the potential to dramatically alter a patient’s life. On the #ACCEL Lite Podcast, Drs. @SJcardio, @SunMoonKimMD & Douglas Weaver discuss Contemporary Therapy in PAD That Every Cardiologist Should Know. https://t.co/rvm6eYu3rG https://t.co/Yd1h1llx9s

  • Mashup Score: 1
    ACCEL Lite: Renal Considerations in the Management of Heart Failure - American College of Cardiology - 9 month(s) ago

    Cardiorenal syndromes cause fluid retention and venous congestion that, in turn, damages the function of vital organs. Providers should have zero tolerance for excessive fluid retention. Aggressive diuretic treatment seems particularly beneficial in patients who are hospitalized for decompensated heart failure. In this interview, Paolo Colombo MD, FACC, and William E. Boden MD, FACC, FAHA, discuss Renal Considerations in the Management of Heart Failure. Keywords: ACCELLite, Heart Failure, Kidney Function

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      Cardiorenal syndromes cause fluid retention & venous congestion that damages the function of vital organs. On a 🆕 episode of #ACCEL Lite podcast, Drs. Paolo Colombo & William E. Boden discuss Renal Considerations in the Management of #HeartFailure. https://t.co/uEVtHPWzlM https://t.co/QLTVHtj5AF

  • Mashup Score: 0
    ACCEL Lite: Managing MVD in STEMI: What We Know and What We Still Need to Learn! - American College of Cardiology - 9 month(s) ago

    Patients with heart attacks often have a lifesaving procedure to open up the narrowed or blocked coronary artery responsible for their heart attack. In about 30-50% of these patients, additional blockages or narrowings that did not cause the heart attack are found. Evidence doesn’t support clinical decision-making on how to identify which of these additional narrowings to open or whether to open all of them. In this interview, Shamir R. Mehta MD, MSc, FACC, and Matt Cavender MD, MPH, FACC, discuss

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      🆕 Episode of the #ACCEL Lite Podcast Listen to Drs. @ShamirMehta and Matt Cavender discuss Managing MVD in #STEMI: What We Know and What We Still Need to Learn! 🎧 Tune in here: https://t.co/X0sdHfnvJe https://t.co/9GtwWlzioC

  • Mashup Score: 2
    ACCEL Lite: Revascularization for Heart Failure - American College of Cardiology - 9 month(s) ago

    In patients with heart failure, viability tests (special heart scans) allow clinicians to distinguish permanently damaged (scarred) parts of the heart from those that may be hibernating and could recover function. Following decades of use based on this theory, the utility of viability tests at predicting prognosis and recovery of heart function has been scientifically tested in the REVIVED Viability study, the results of which could dramatically change the way heart failure patients are assessed and

    Source: www.acc.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      🆕 Episode of the #ACCEL Lite Podcast Listen to Divaka Perera MD, FRCP, @divaka_perera and Matt Cavender MD, MPH, FACC discuss the details around #revasc for #heartfailure. https://t.co/ZigRxiys1q https://t.co/gZiEItFtv7

Load More